Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayanth Panyam

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Scientific Reports|February 9, 2021
Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)Vidhi Khanna, Hyunjoon Kim, Wenqiu Zhang, et al.
Journal of Immunological Methods|August 3, 2010
Identification of a novel monoclonal antibody recognizing CD133Suresh Kumar Swaminathan, Michael R Olin, Colleen L Forster, et al.
Molecular Pharmaceutics|August 21, 2007
Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug effluxMahesh D Chavanpatil, Ayman Khdair, Brigitte Gerard, et al.
International Journal of Pharmaceutics|October 15, 2014
Intranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailabilityJung Min Song, Ameya R Kirtane, Pramod Upadhyaya, et al.
Biomaterials|June 10, 2011
Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticlesUdaya S Toti, Bharath R Guru, Mirabela Hali, et al.
Molecular Pharmaceutics|May 9, 2020
TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer ImmunotherapyHyunjoon Kim, Vidhi Khanna, Tamara A Kucaba, et al.
International Journal of Nanomedicine|June 28, 2014
Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapySumit Arora, Suresh K Swaminathan, Ameya Kirtane, et al.
Molecular Pharmaceutics|June 13, 2015
Reformulating Tylocrebrine in Epidermal Growth Factor Receptor Targeted Polymeric Nanoparticles Improves Its Therapeutic IndexAmeya R Kirtane, Henry L Wong, Bharath Raja Guru, et al.
Cancers|December 23, 2022
Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer ImmunotherapyShubhmita Bhatnagar, Vishnu Revuri, Manan Shah, et al.
Drug Delivery and Translational Research|March 20, 2015
Immunotoxin targeting CD133(+) breast carcinoma cellsJohn R Ohlfest, David M Zellmer, Jayanth Panyam, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Scientific Reports|February 9, 2021
Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)Vidhi Khanna, Hyunjoon Kim, Wenqiu Zhang, et al.
Journal of Immunological Methods|August 3, 2010
Identification of a novel monoclonal antibody recognizing CD133Suresh Kumar Swaminathan, Michael R Olin, Colleen L Forster, et al.
Molecular Pharmaceutics|August 21, 2007
Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug effluxMahesh D Chavanpatil, Ayman Khdair, Brigitte Gerard, et al.
International Journal of Pharmaceutics|October 15, 2014
Intranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailabilityJung Min Song, Ameya R Kirtane, Pramod Upadhyaya, et al.
Biomaterials|June 10, 2011
Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticlesUdaya S Toti, Bharath R Guru, Mirabela Hali, et al.
Molecular Pharmaceutics|May 9, 2020
TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer ImmunotherapyHyunjoon Kim, Vidhi Khanna, Tamara A Kucaba, et al.
International Journal of Nanomedicine|June 28, 2014
Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapySumit Arora, Suresh K Swaminathan, Ameya Kirtane, et al.
Molecular Pharmaceutics|June 13, 2015
Reformulating Tylocrebrine in Epidermal Growth Factor Receptor Targeted Polymeric Nanoparticles Improves Its Therapeutic IndexAmeya R Kirtane, Henry L Wong, Bharath Raja Guru, et al.
Cancers|December 23, 2022
Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer ImmunotherapyShubhmita Bhatnagar, Vishnu Revuri, Manan Shah, et al.
Drug Delivery and Translational Research|March 20, 2015
Immunotoxin targeting CD133(+) breast carcinoma cellsJohn R Ohlfest, David M Zellmer, Jayanth Panyam, et al.
Pageof 9